中醫醫經
0
Quality Score
Niche
✍️ bumetric analysis
“
中醫醫經 is an Android app from Stoxline in the Books & Reference category, currently rated — across few ratings. Initial signal reads as mixed reviews: supporters praise core features while critics cite stability and value gaps.
Quality Score is 0: Niche (micro-niche or pre-traction stage). For a Books & Reference app, that means micro-niche or pre-traction stage. The full BU Investment Matrix below scores 8 dimensions including monetisation, growth, and operational risk.
Track changes month-over-month in the Performance section below: live snapshot history and revenue forecast included.
💰 Monthly revenue · now vs forecast
● Right now
$500
per month
→
12-mo forecast
$437 – $1575
per month
→
24-mo forecast
$405 – $3644
per month
INDIE tier
💡 Grow this revenue
Free AI audit of this app’s store listing
- Title & subtitle keyword fit
- Description hook & conversion structure
- Screenshots, ratings, reviews strategy
Typical impact: +2-5× organic installs
📊 Performance Tracking LIVE
Loading…
Rating
—
Reviews
—
Forecast Revenue / mo
—
Snapshots tracked
0
since first record
ONE-TIME · BUILD
💰 Estimated build cost
$75K
↳ What it cost to build · not monthly revenue
Likely range $55K – $100K
$25K · MVP floor
$100K · indie scale
$500K+ · studio build
📈
Slow ROI — current MRR is well below build cost
Synthetic estimate. Inputs: category complexity, file size, screen count, monetization layer, platform reach, age × team-size proxy. Calibrated against 2024-2026 indie-agency rate surveys. Full math + source list on /methodology.
Where the money goes
| 🧱 MVP baseline (design + 1-store ship) | +$28K |
| 📱 5 unique screens × $4.5K | +$22K |
| ⚙ Books & Reference complexity ×0.95 | $-2525 |
| 🌐 Cross-platform reach (iOS + Android) | +$26K |
Total estimate
$75K
🔬
How we forecast this revenue
LOW CONFIDENCEBaseline
$500/mo · ML-estimated from 234 triggers
Growth rate
+6.0% MoM · INDIE tier baseline (compound monthly)
Direction
Headwinds: rating drift may slow acquisition
6 months
$426 – $993
12 months
$437 – $1.6K
24 months
$405 – $3.6K
Compound growth at +6.0% MoM (tier baseline for INDIE). Range widens with horizon — typical noise band ±40% at 6mo.. Ranges widen with horizon — distant futures carry more uncertainty.
📊
BU Investment Matrix
Pre-traction · 35/100INDIE TIERlimited signalRevenue Strength
2.7
Product Quality
0.0
Market Position
0.0
Growth Velocity
5.0
Defensibility
7.4
Operational Safety
7.0
Founder Strength
5.2
Monetization Maturity
1.0
- 💰 Revenue: Marginal — $200 - $1250/mo · INDIE tier · medium confidence, trajectory unclear.
- ⭐ Quality: None★ across 0 reviews — weak — significant quality concerns.
- 📍 Market: Not yet charting in any of the 9 monitored markets.
- 📈 Growth: ⚠ last update 719d ago — possibly dormant.
- ⚠️ Risk: Moderate — dormant (719d since update).
🎯 For competitors: Mixed picture. Worth competing if you have a clear UX or pricing edge — otherwise crowded segment.
💵 For acquirers: Estimated asking range 18-32× monthly = $9K-$16K.
Composite of 8 dimensions computed deterministically from public signals — no LLM, every score traces back to a measurable input. Default weights shown; "compete" / "acquire" / "invest" lenses re-weight without re-fetching.
Range:
💰 Forecast Revenue / mo
MODELRevenue forecast computed from BU's 234 trigger model on each snapshot. Calibrated against ground-truth from 58 verified-revenue apps.
📈 Reviews Growth
LIVECumulative review count from first BU snapshot. Each point = a tracked update.
⭐ Rating Trend
LIVEAverage rating evolution. Updates with each new review batch.
Profile & Insights
Everything we know — and don't — about this app and its company.
Identification
- App name
- 中醫醫經
- Developer
- Stoxline
- Bundle ID
- com.stoxline.yijingfanti
- App Store URL
- Open in App Store
- Category
- Books & Reference
- Content rating
- Not found
- Languages
- Not found
Company
- Website
- www.stoxline.com
- Tagline
- Not found
- Description
- Not found
- Founded
- Not found
- HQ / Address
- Not found
- Employees
- Not found
- Logo
- Not found
Revenue
- Verified revenue / mo
- Not found
- AI revenue estimate / mo
- Not found
- AI annual estimate
- Not found
- ML model estimate / mo
- $228/mo
- Top-grossing rank
- Not found
- All-time revenue
- Not found
- Pricing
- Not found
Founder
Founder data not yet collected for this app.
Funding
Funding data not yet collected for this app.
Press & Links
Press & Links data not yet collected for this app.
Contacts & Socials
Contacts & Socials data not yet collected for this app.
Profile is built from iTunes Lookup + developer site scrape + ML revenue model. Empty fields show "Not found" — additional sources (Crunchbase, X, IndieHackers, Acquire.com) coming.
📝 About this app
本應用是《中醫醫經》的繁體版，簡體版見下面的鏈接。《中醫醫經》是中醫學術古典著作、古代四種“方技之書”之一。
《讀素問鈔》 元·滑壽
《古本難經闡注》 清·丁錦
《黃帝內經靈樞》 戰國·東漢
《黃帝內經素問》 戰國·黃帝
《黃帝內經素問集注》 清·張志聰
《黃帝內經太素》 隋·楊上善
《黃帝素問直解》 清·高士宗
《類經》 明·張景岳
《靈樞懸解》 清·黃元御
《靈素節注類編》 清·章虛谷
《內經博議》 清·羅美
《內經評文》 清·周學海
《內經知要》 明·李中梓
《難經》 戰國·扁鵲
《難經集注》 宋·王惟一
《難經經釋》 清·徐大椿
《難經懸解》 清·黃元御
《難經正義》 清·葉霖
《素問識》 丹波元簡
《素問懸解》 清·黃元御
《伊尹湯液經》 漢·仲景
《醫經原旨》 清·薛雪
應用特點：
1.免費，離線閱讀。
2.書簽功能。
3.字體，亮度隨意設置，夜晚模式保護視力。
4.按章節隨意閱讀。
5.可跳轉頁碼閱讀。
此應用是《中醫醫經》的繁體版，如果想安裝簡體版，可點此下載：
https://play.google.com/store/apps/details?id=com.stoxline.zhongyiyijing
《讀素問鈔》 元·滑壽
《古本難經闡注》 清·丁錦
《黃帝內經靈樞》 戰國·東漢
《黃帝內經素問》 戰國·黃帝
《黃帝內經素問集注》 清·張志聰
《黃帝內經太素》 隋·楊上善
《黃帝素問直解》 清·高士宗
《類經》 明·張景岳
《靈樞懸解》 清·黃元御
《靈素節注類編》 清·章虛谷
《內經博議》 清·羅美
《內經評文》 清·周學海
《內經知要》 明·李中梓
《難經》 戰國·扁鵲
《難經集注》 宋·王惟一
《難經經釋》 清·徐大椿
《難經懸解》 清·黃元御
《難經正義》 清·葉霖
《素問識》 丹波元簡
《素問懸解》 清·黃元御
《伊尹湯液經》 漢·仲景
《醫經原旨》 清·薛雪
應用特點：
1.免費，離線閱讀。
2.書簽功能。
3.字體，亮度隨意設置，夜晚模式保護視力。
4.按章節隨意閱讀。
5.可跳轉頁碼閱讀。
此應用是《中醫醫經》的繁體版，如果想安裝簡體版，可點此下載：
https://play.google.com/store/apps/details?id=com.stoxline.zhongyiyijing
App Specs
🔐 Own this app? Claim & verify MRR →🔖 v2.7.5🔄 updated 0d ago📂 Books & Reference💰 Free📺 Ad-supported
🔔
Track this app’s revenue
FREEGet an email when revenue moves by your threshold. No spam, unsubscribe in one click.
📝 Description
95
BU Score · Transcendent
More by Stoxline
View all →📦 Portfolio summaryINDIE studio
40apps·$447/mocombined
✓ Diversified — top app contributes 26%; risk spread across portfolio
About this analysis
Why low confidence: only 0 ratings · no founder-verified revenue (model estimate only) · revenue figure is directional only.
📌 Final verdict — read this before you trust the numbers above
中醫醫經 is a very early-stage Android app in the books & reference space with weak public traction — only 0 ratings, no founder-verified MRR, and not ranked in any monitored grossing chart. The app appears to be monetised, but public signals are too sparse for a precise revenue estimate.
Bottom line: treat all revenue, audience and acquisition-value numbers on this page as directional only — not founder-verified facts.
❓ Frequently Asked Questions
3 answers · auto-generated from this app's public dataHow much does 中醫醫經 make per month?▴
Low-confidence model estimate. 中醫醫經 has only 0 App Store ratings, so our revenue model has very little signal to work with — treat the ~$227/mo figure as directional only, not a verified MRR. No founder-verified revenue data is available for this app. See methodology for the formula and confidence bands.
What apps are like 中醫醫經?▴
Browse the full Books & Reference category catalog to find similar apps with revenue, build cost, audience and tech stack data. Each /p/{slug} page also shows a Compare side-by-side widget with three peer apps from the same niche.
Who makes 中醫醫經?▴
中醫醫經 is published by Stoxline on the Google Play Store. See the full publisher portfolio (other apps by the same developer) via the More by developer block on the product page above.